• 1
    Manyonda I, Sinthamoney E, Belli A-M. Controversies and challenges in the fibroid management of uterine fibroids. BJOG 2004;111:95102.
  • 2
    Stewart EA. Uterine fibroids. Lancet 2001;357:2938.
  • 3
    Banu NS, Manyonda I. Alternative medical and surgical options to hysterectomy. Best Pract Res Clin Obstet Gynaecol 2005;19:43149.
  • 4
    Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:1007.
  • 5
    Stewart E, Rabinovici J, Tempany C, Inbar Y, Regan L, Gastout B, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85:229.
  • 6
    Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynnen K et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol 2004;183:171319.
  • 7
    Smart OC, Hindley JT, Regan L, Gedroyc WG. Magnetic resonance guided focused ultrasound surgery of uterine fibroids—the tissue effects of GnRH agonist pre-treatment. Eur J Radiol 2006;59:1637.
  • 8
    Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol 2006;108:4954.
  • 9
    Stewart E, Gedroyc W, Tempany C, Quade B, Inbar Y, Ehrenstein T, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003;189:4854.
  • 10
    McDannold N, Clare M, Tempany CM, Fennessy FM, So MJ, Rybicki FJ, et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 2006;240:26372.
  • 11
    National Institute for Clinical Excellence. Guide to the methods of technology appraisal. London, UK: National Institute for Clinical Excellence, April 2004.
  • 12
    The UK Government Actuary Department. Interim Life Tables, Expectation of Life, United Kingdom, Females, 2002–2004. London, UK: The UK Government Actuary Department 2006.
  • 13
    Hart R, Molnár BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999;106:7005.
  • 14
    McPherson K, Metcalfe MA, Herbert A, Maresh M, Casbard A, Hargreaves J, et al. Severe complications of hysterectomy: the VALUE study. BJOG 2004;111:68894.
  • 15
    Garry R, Fountain J, Mason S, Hawe J, Napp V, Abbott J, et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, and the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004. DOI:10.1136/bmj.37984.623889.F6.
  • 16
    Spies J, Cooper J, Worthington-Kirsch R, Lipman J, Mills B, Benenati J. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 2004;191:2231.
  • 17
    Garside R, Stein K, Wyatt K, Round A, Pitt M. A cost–utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG 2004;111:110314.
  • 18
    Emanuel MH, Wamsteker K, Hart AAM, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999;93:7438.
  • 19
    Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M. The FIBROID registry: Symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005;106:130918.
  • 20
    The UK Department of Health. NHS reference costs 2005. London, UK: The UK Department of Health 2006.
  • 21
    Curtis L, Netten A. Unit costs of health and social care 2004. Canterbury, UK: Personal Social Services Research Unit (PSSRU), University of Kent 2004.
  • 22
    British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, 51st edn. London, UK: British Medical Association and Royal Pharmaceutical Society of Great Britain 2006.
  • 23
    Fennessy F, Tempany C, McDannold N, So M, Hesley G, Gostout B, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery – results of different treatment protocols. Radiology 2007;243:88597.
  • 24
    Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 2005;31:10545.
  • 25
    Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivelä A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia. JAMA 2004;291:145663.
  • 26
    Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivelä A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:2737.
  • 27
    Kuppermann M, Varner RE, Summitt RL, Learman LA, Ireland C, Vittinghoff E, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:144755.
  • 28
    Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:27192.
  • 29
    Sculpher M, Manca A, Abbott J, Fountain J, Mason, Garry R. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial (Epub 2004 Jan 7). BMJ 2004;328:134.
  • 30
    Clark TJ, Mahajan D, Sunder P, Gupta JK. Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study. Eur J Obstet Gynecol Reprod Biol 2002;100:23742.
  • 31
    Al-Fozan H, Dufort J, Kaplow M, Valenti D, Tulandi T. Cost analysis of myomectomy, hysterectomy, and uterine artery embolization. Am J Obstet Gynecol 2002;187:14014.
  • 32
    Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 2005;105:87781.
  • 33
    Scottish Health Statistics. Prescription Cost Analysis for Scotland 2005. Edinburgh, UK: Scottish Health Statistics 2006.
  • 34
    Sculpher M. A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. Int J Technol Assess Health Care 1998;14:30219.
  • 35
    Garside R, Stein K, Wyatt K, Round A, Price A. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. Health Technol Assess 2004;8:3.
  • 36
    Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC. Management of uterine leiomyomata: what do we really know? Obstet Gynecol 2002;100:817.
  • 37
    Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids (Review). Copyright © 2006. The Cochrane Collaboration, John Wiley & Sons, Ltd; Issue 1: CD005073.
  • 38
    The REST Investigators. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007;356:36070.
  • 39
    AHRQ. Managements of uterine fibroids. Rockville, MD: Technology Assessment Agency for Healthcare Research and Quality, 2000. Evidence Report Number 34.
  • 40
    Hanstede MMF, Tempany CMC, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report, Fertil Steril 2007. DOI:10.1016/j.fertnstert.2006.11.103
  • 41
    Gavrilova-Jordan LP, Rose CH, Traynor KD, Brost BC, Gostout BS. Successful term pregnancy following mr-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol 2007;27:5961.
  • 42
    Rabinovici J, Inbar Y, Eylon-Cohen S, Schiff E, Hananel A, Freundlich D. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Human Reprod 2006;21:12559.
  • 43
    Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996.
  • 44
    Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. New York, NY: Oxford University Press, 2005.